To include your compound in the COVID-19 Resource Center, submit it here.

Merck, Aralez deal

Aralez purchased U.S. and Canadian rights to Zontivity vorapaxar from Merck. The

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE